Related Experiment Video
Updated: Jun 28, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Optimizing the care management pathway of patients with ischemia and non-obstructive coronary arteries]
Fabrizio Oliva1, Giuseppe Boriani2, Paolo Calabrò3
1Cardiologia 1-Emodinamica, ASST Grande Ospedale Metropolitano Niguarda, Milano.
Insights
Ischemia with non-obstructive coronary arteries (INOCA) is a common condition often underdiagnosed. This initiative aimed to standardize INOCA diagnosis and management, improving patient care and outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Vascular Biology
Context:
- Ischemia with non-obstructive coronary arteries (INOCA) presents with anginal symptoms and ischemia but no obstructive coronary artery disease.
- Coronary microvascular dysfunction and vasospasm are key underlying mechanisms in INOCA.
- INOCA patients experience recurrent symptoms, functional limitations, reduced quality of life, and increased cardiovascular events.
Purpose:
- To disseminate evidence on INOCA as a distinct clinical entity.
- To develop uniform and shared management pathways for INOCA patients.
- To improve the diagnosis and management of INOCA across various clinical settings.
Summary:
- A 2022 clinical practice improvement initiative involved 30 cardiology units nationwide.
- The initiative focused on standardizing the diagnosis and management of INOCA.
- Outcomes of this multidisciplinary effort are presented to guide clinical practice.
Impact:
- Addresses the underdiagnosis of INOCA due to lack of awareness and standardized diagnostic tools.
- Aims to improve the quality of life and reduce cardiovascular events in INOCA patients.
- Promotes consistent and effective management strategies for INOCA across different healthcare settings.
Abstract:
Ischemia with non-obstructive coronary arteries (INOCA) is defined by the coexistence of anginal symptoms and demonstrable ischemia, with no evidence of obstructive coronary arteries. The underlying mechanism of INOCA is coronary microvascular dysfunction with or without associated vasospasm. INOCA patients have recurrent symptoms, functional limitations, repeated access to the emergency department, impaired quality of life and a higher incidence of cardiovascular events than the general population. Although well described in chronic coronary syndrome guidelines, INOCA remains underdiagnosed in clinical practice because of insufficient awareness, lack of accurate diagnostic tools, and poorly standardized and consistent definitions to diagnose, both invasively and non-invasively, coronary microvascular dysfunction.To disseminate current scientific evidence on INOCA as a distinct clinical entity, during 2022 we conducted at 30 cardiology units all over the country a clinical practice improvement initiative, with the aim of developing uniform and shared management pathways for INOCA patients across different operational settings. The present document highlights the outcomes of this multidisciplinary initiative.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation